DM

Dean Y. Maeda

SB Syntrix Biosystems: 15 patents #2 of 6Top 35%
US Ucb S.A.: 1 patents #92 of 218Top 45%
Overall (All Time): #272,677 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
RE48547 Aminopyrimidinecarboxamides as CXCR2 modulators John A. Zebala, Aaron D. Schuler 2021-05-11
10993953 Method for treating cancer using chemokine antagonists John A. Zebala, Aaron D. Schuler 2021-05-04
10660909 Method for treating cancer using chemokine antagonists John A. Zebala, Aaron D. Schuler 2020-05-26
RE47740 Aminopyridinecarboxamides as CXCR2 modulators John A. Zebala, Aaron D. Schuler 2019-11-26
RE47415 Pyrimidinecarboxamides as CXCR2 modulators John A. Zebala 2019-06-04
RE47267 Pyridinecarboxamides as CXCR2 modulators John A. Zebala 2019-03-05
10130645 Use of thiopyrimidinecarboxamide for treating cancer John A. Zebala, Aaron D. Schuler 2018-11-20
10046002 Method for treating cancer using chemokine antagonists John A. Zebala, Aaron D. Schuler 2018-08-14
9707248 Use of thiopyrimidinecarboxamide for treating cancer John A. Zebala, Aaron D. Schuler 2017-07-18
9480694 Thiopyrimidinecarboxamide for use in treating pulmonary disease John A. Zebala, Aaron D. Schuler 2016-11-01
8993541 Aminopyrimidinecarboxamides as CXCR2 modulators John A. Zebala, Aaron D. Schuler 2015-03-31
8981106 Pyrimidinecarboxamides as CXCR2 modulators John A. Zebala 2015-03-17
8969365 Thiopyrimidinecarboxamides as CXCR1/2 modulators John A. Zebala, Aaron D. Schuler 2015-03-03
8779149 Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators John A. Zebala, Aaron D. Schuler 2014-07-15
8748623 Pyridinecarboxamides as CXCR2 modulators John A. Zebala 2014-06-10
8349837 Pharmaceutical composition comprising racemic aminopterin John A. Zebala, Joel R. Morgan, Stuart J. Kahn 2013-01-08
7176310 Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents Theodore A. Baughman, Jim P. Boyce, Ihab Darwish, J. Jeffry Howbert, Nathan Ihle +3 more 2007-02-13